Bioventix PLC (BVXP.L) Research

Bioventix PLC focuses on the development, manufacturing, and global provision of sheep monoclonal antibodies (SMAs) for various diagnostic purposes. The company's extensive product line features purified SMAs that facilitate testing for critical areas such as thyroid conditions, vitamin D deficiencies, cardiac health markers, detection of drugs of abuse, fertility assessments, infectious diseases, oncology, and other diverse medical indications. Additionally, Bioventix PLC offers tailored contract SMA development and specialized recombinant services. The London, UK-based firm was established in 2003.

Market snapshot

Symbol
BVXP.L
Price
$1,745
Day change
-4.38%
Market cap
$91.2M
P/E ratio
12.29x
52-week range
1300-3020
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 4 months

Peer companies

  • 4basebio PLC (4BB.L)
  • Arecor Therapeutics plc (AREC.L)
  • Diaceutics PLC (DXRX.L)
  • EKF Diagnostics Holdings plc (EKF.L)
  • Hemogenyx Pharmaceuticals Plc (HEMO.L)
  • hVIVO plc (HVO.L)
  • ImmuPharma plc (IMM.L)
  • Ondine Biomedical Inc. (OBI.L)

Open Bioventix PLC (BVXP.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.